27 February 2026
27 February 2026
Ahead of Rare Disease Day, Abigail Beaney, editor of Clinical Trials Arena, spoke with Robert Barrie, editor of Pharmaceutical Technology and Frankie Fattorini, reporter for Pharmaceutical Technology and GlobalData Insights, about some of the recent developments in the rare disease space.
Several new guidance documents issued by the FDA are poised to significantly impact the rare disease development landscape.
Généthon CEO Frédéric Revah says alternative patient access approaches are needed for ultra rare diseases.
The company anticipates the deal to positively impact operating income from fiscal 2028 onwards.
The agreement includes Ipsen’s investment in additional equipment at Quotient Sciences’ facility in Boothwyn, Pennsylvania, US.
The organised crime group were selling unlicensed weight loss-substances online, using social media to market products.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
